WallStSmart
GLMD

Galmed Pharmaceuticals Ltd

NASDAQ: GLMD · HEALTHCARE · BIOTECHNOLOGY

$0.58
-4.67% today

Updated 2026-06-05

Market cap
$4.59M
P/E ratio
P/S ratio
61.38x
EPS (TTM)
$-2.39
Dividend yield
52W range
$0 – $2
Volume
3.8M

Galmed Pharmaceuticals Ltd (GLMD) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item201120122013201420152016201720182019202020212022202320242025
Total assets$762000.00$166000.00$32.92M$24.26M$16.45M$19.64M$90.60M$77.14M$52.38M$36.60M$16.56M$16.63M$18.50M$18.63M
Cash & equivalents$718000.00$137000.00$23.74M$4.16M$3.10M$13.02M$24.16M$15.93M$6.95M$2.88M$2.02M$2.86M$4.65M$3.98M
Current assets$732000.00$153000.00$32.15M$23.38M$15.73M$19.15M$90.41M$76.43M$51.81M$36.05M$14.72M$13.24M$16.12M$18.63M
Total liabilities$2.74M$2.12M$1.52M$2.72M$5.38M$3.85M$2.71M$7.29M$8.23M$6.11M$3.14M$2.75M$2.17M$2.85M
Current liabilities$513000.00$1.69M$1.12M$2.54M$4.58M$3.85M$2.71M$6.93M$8.01M$5.88M$3.09M$2.75M$2.17M$2.85M
Long-term debt$1.82M
Shareholder equity$-1.98M$-1.95M$31.41M$21.55M$11.07M$15.79M$87.89M$69.85M$44.15M$30.50M$13.42M$13.88M$16.33M$15.78M
Retained earnings$-10.16M$-27.64M$-36.74M$-47.37M$-64.32M$-76.62M$-86.47M$-106.94M$-135.71M$-168.17M$-186.04M$-192.95M$-200.47M$-210.78M
Accounts receivable$10000.00$11000.00$64000.00$109000.00$284000.00$155000.00$51000.00$226000.00$66000.00$79000.00$157000.00$165000.00$209000.00$80000.00
Inventory$-5.90M$-270000.00$-254000.00$-100000.00$-27.94M$-3.81M$-932000.00$114000.00
Goodwill

Frequently asked questions

How much free cash flow does GLMD generate?

GLMD produced $-6.32M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is GLMD's balance sheet healthy?

GLMD holds $3.98M in cash and equivalents against — in long-term debt, on $15.78M of shareholder equity. That debt is best read against the cash flow the business throws off each year.